![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » FDA Gives Emergency Clearance to Roche’s COVID-19/Influenza Test
FDA Gives Emergency Clearance to Roche’s COVID-19/Influenza Test
![emergency use authorization approved](https://www.fdanews.com/ext/resources/test/Drug-Images4/emergency-use-authorization-EUA-approved.gif?t=1586211479&width=430)
Roche has received an Emergency Use Authorization from the FDA for its SARS-CoV-2 and influenza A&B test.
The diagnostic is used on Roche’s cobas 6800 and 8800 systems and is designed for high-volume testing, providing up to 96 test results in approximately three hours.
The product is the first commercial test for automated high-throughput systems that can identify and differentiate between SARS-CoV-2, influenza A and influenza B using a single sample, according to the company.
Upcoming Events
-
21Oct